The Houston Methodist Hospital has suspended the privileges of Dr. Mary Bowden.
On Twitter, she repeatedly defended the anti-parasitical drug Ivermectin as a COVID-19 treatment.
Bowden is the latest doctor to face disciplinary measures after going against COVID-19 guidelines backed by leading health officials.
A doctor from Texas who spread COVID-19 misinformation on her personal Twitter account has had her privileges suspended.
Ivermectin is a drug typically used to treat parasitic infections in livestock like horses. Health agencies like the Centers for Disease Control and Prevention and the Food and Drug Administration have repeatedly warned that the drug can cause adverse side effects in humans, like dizziness and nausea. In some cases, it can lead to overdose and death, as well as hallucinations and seizures.
Ivermectin can be used by humans but only through a prescription ordered by a doctor, usually to get rid of parasitic worms, according to the FDA. Sometimes, ivermectin can be used to treat lice and skin conditions like rosacea. But no health agency recommends that people infected with the coronavirus take ivermectin.
Bowden’s attorney Steven Mitby told CNN that the doctor is not against vaccines but rather believes that “people should have a choice.” Bowden is vaccinated, Mitby said, as Houston Methodist mandates that all doctors be fully vaxxed against COVID-19.
In a statement posted to Twitter, the Houston Methodist Hospital said Bowden used her account to “express her personal and political opinions about the COVID-19 vaccine and treatments.”
Bowden is the latest doctor to face discipline after going against COVID-19 guidelines that are backed by leading health officials nationwide.
Last month, retired physician Sue McIntosh voluntarily surrendered her medical license after officials learned she was giving patients blank, signed COVID-19 exemption waivers. And in September, Steven Arthur LaTulippe had his medical license revoked after he falsely described carbon-dioxide poisoning as a risk of wearing face masks.
Read the original article on Business Insider